메뉴 건너뛰기




Volumn 85, Issue 4, 2012, Pages 425-427

Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz

Author keywords

Antiretroviral therapy; Contraceptive failure; Drug interactions; Efavirenz; Etonogestrel implant

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ETONOGESTREL; LAMIVUDINE; ZIDOVUDINE;

EID: 84858336081     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.09.005     Document Type: Article
Times cited : (51)

References (16)
  • 1
    • 15744396784 scopus 로고    scopus 로고
    • Unintended pregnancies with the etonogestrel implant (Implanon): A case series from postmarketing experience in Australia
    • DOI 10.1016/j.contraception.2004.10.005
    • M. Harrison-Woolrych, and R. Hill Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia Contraception 71 2005 306 308 (Pubitemid 40410081)
    • (2005) Contraception , vol.71 , Issue.4 , pp. 306-308
    • Harrison-Woolrych, M.1    Hill, R.2
  • 2
    • 29344447816 scopus 로고    scopus 로고
    • Failure of implanon contraception in a patient taking carbamazepin for epilepsia
    • DOI 10.1007/s00404-005-0064-4
    • C. Schindlbeck, W. Janni, and K. Friese Failure of Implanon contraception in a patient taking carbamazepine for epilepsia Arch Gynecol Obstet 273 2006 255 256 (Pubitemid 43004702)
    • (2006) Archives of Gynecology and Obstetrics , vol.273 , Issue.4 , pp. 255-256
    • Schindlbeck, C.1    Janni, W.2    Friese, K.3
  • 3
    • 47349093975 scopus 로고    scopus 로고
    • Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives
    • DOI 10.1080/13625180701829952, PII 789300048
    • S.Y. El-Ibiary, and J.M. Cocohoba Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives Eur J Contracept Reprod Health Care 13 2008 123 132 (Pubitemid 352000659)
    • (2008) European Journal of Contraception and Reproductive Health Care , vol.13 , Issue.2 , pp. 123-132
    • El-Ibiary, S.Y.1    Cocohoba, J.M.2
  • 4
    • 0032955402 scopus 로고    scopus 로고
    • Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection
    • DOI 10.2165/00003088-199936040-00004
    • M. Barry, F. Mulcahy, C. Merry, S. Gibbons, and D. Back Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection Clin Pharmacokinet 36 1999 289 304 (Pubitemid 29201737)
    • (1999) Clinical Pharmacokinetics , vol.36 , Issue.4 , pp. 289-304
    • Barry, M.1    Mulcahy, F.2    Merry, C.3    Gibbons, S.4    Back, D.5
  • 5
    • 33846592800 scopus 로고    scopus 로고
    • Depo-medroxyprogesterone in women on antiretroviral therapy: Effective contraception and lack of clinically significant interactions
    • DOI 10.1038/sj.clpt.6100040, PII 6100040
    • S.E. Cohn, J.G. Park, D.H. Watts, A. Stek, J. Hitti, and P.A. Clax Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions Clin Pharmacol Ther 81 2007 222 227 (Pubitemid 46174819)
    • (2007) Clinical Pharmacology and Therapeutics , vol.81 , Issue.2 , pp. 222-227
    • Cohn, S.E.1    Park, J.-G.2    Watts, D.H.3    Stek, A.4    Hitti, J.5    Clax, P.A.6    Yu, S.7    Lertora, J.J.L.8
  • 6
    • 38349121002 scopus 로고    scopus 로고
    • Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093
    • D.H. Watts, J.G. Park, S.E. Cohn, S. Yu, J. Hitti, and A. Stek Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093 Contraception 77 2008 84 90
    • (2008) Contraception , vol.77 , pp. 84-90
    • Watts, D.H.1    Park, J.G.2    Cohn, S.E.3    Yu, S.4    Hitti, J.5    Stek, A.6
  • 7
    • 0035696398 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors
    • P.F. Smith, R. DiCenzo, and G.D. Morse Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors Clin Pharmacokinet 40 2001 890 905
    • (2001) Clin Pharmacokinet , vol.40 , pp. 890-905
    • Smith, P.F.1    Dicenzo, R.2    Morse, G.D.3
  • 8
    • 79953192509 scopus 로고    scopus 로고
    • The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women
    • H. Sevinsky, T. Eley, A. Persson, D. Garner, C. Yones, and R. Nettles The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women Antivir Ther 16 2011 149 156
    • (2011) Antivir Ther , vol.16 , pp. 149-156
    • Sevinsky, H.1    Eley, T.2    Persson, A.3    Garner, D.4    Yones, C.5    Nettles, R.6
  • 9
    • 0036177385 scopus 로고    scopus 로고
    • Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: The analysis of pooled data
    • PII S0015028201032757
    • M. Zieman, J. Guillebaud, E. Weisberg, G.A. Shangold, A.C. Fisher, and G.W. Creasy Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data Fertil Steril 77 2002 S13 S18 (Pubitemid 34155400)
    • (2002) Fertility and Sterility , vol.77 , Issue.SUPPL. 2
    • Zieman, M.1    Guillebaud, J.2    Weisberg, E.3    Shangold, G.A.4    Fisher, A.C.5    Creasy, G.W.6
  • 10
    • 0037382754 scopus 로고    scopus 로고
    • Ortho Evra, a new contraceptive patch
    • DOI 10.1592/phco.23.4.472.32120
    • B.L. Sicat Ortho Evra, a new contraceptive patch Pharmacotherapy 23 2003 472 480 (Pubitemid 36384326)
    • (2003) Pharmacotherapy , vol.23 , Issue.4 , pp. 472-480
    • Sicat, B.L.1
  • 11
    • 0028845630 scopus 로고
    • Pre-introductory clinical trials of Norplant implants: A comparison of seventeen countries' experience
    • G.S. Grubb, D. Moore, and N.G. Anderson Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience Contraception 52 1995 287 296
    • (1995) Contraception , vol.52 , pp. 287-296
    • Grubb, G.S.1    Moore, D.2    Anderson, N.G.3
  • 12
  • 14
    • 0032799860 scopus 로고    scopus 로고
    • Health effects of long-term use of the intrauterine levonorgestrel- releasing system. A follow-up study over 12 years of continuous use
    • M. Ronnerdag, and V. Odlind Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use Acta Obstet Gynecol Scand 78 1999 716 721 (Pubitemid 29392677)
    • (1999) Acta Obstetricia et Gynecologica Scandinavica , vol.78 , Issue.8 , pp. 716-721
    • Ronnerdag, M.1    Odlind, V.2
  • 15
    • 0035034161 scopus 로고    scopus 로고
    • The levonorgestrel intrauterine system: More than a contraceptive
    • K. Andersson The levonorgestrel intrauterine system: more than a contraceptive Eur J Contracept Reprod Health Care 6 2001 15 22
    • (2001) Eur J Contracept Reprod Health Care , vol.6 , pp. 15-22
    • Andersson, K.1
  • 16
    • 0034471468 scopus 로고    scopus 로고
    • Contraception with a novel 'frameless' intrauterin levonorgestrel- releasing drug delivery system: A pilot study
    • D. Wildemeersch, and E. Schacht Contraception with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study Eur J Contracept Reprod Health Care 5 2000 234 240 (Pubitemid 32165461)
    • (2000) European Journal of Contraception and Reproductive Health Care , vol.5 , Issue.4 , pp. 234-240
    • Wildemeersch, D.1    Schacht, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.